Elan Vote Puts Royalty's $8B Hostile Bid In Doubt
The $8 billion battle for Elan Corp. PLC hinges on an Irish court hearing this week after Elan shareholders approved a share buyback Monday, which will force Royalty Pharma Inc. to...To view the full article, register now.
Already a subscriber? Click here to view full article